Post-chemotherapy cognitive impairment
IMPAIRMENT THAT CAN RESULT FROM CHEMOTHERAPY TREATMENT
Chemobrain; Chemo brain; Chemo fog; Chemotherapy-induced cognitive dysfunction; Chemofog; Chemotherapy induced cognitive decline; Chemotherapy-induced cognitive decline; Chemotherapy-induced cognitive impairment; CRCI; Chemotherapy-Related Cognitive Impairment
Post-chemotherapy cognitive impairment (PCCI) (also known in the scientific community as "CRCIs or Chemotherapy-Related Cognitive Impairments" and in lay terms as chemotherapy-induced cognitive dysfunction or impairment, chemo brain, or chemo fog) describes the cognitive impairment that can result from chemotherapy treatment. Approximately 20 to 30% of people who undergo chemotherapy experience some level of post-chemotherapy cognitive impairment.